RecruitingNot ApplicableNCT04997473

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients


Sponsor

University of California, Los Angeles

Enrollment

20 participants

Start Date

Aug 15, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addictive eating habits, and motivation for change.


Eligibility

Min Age: 13 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called W8L2G mobile health (mHealth) app for people with obesity and stem cell transplant. The study is currently recruiting participants at 1 location. People eligible for this study include aged 13 Years to 30 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALW8L2G mobile health (mHealth) app

Weight loss phone app based on addiction principles. This intervention has been validated in two prior studies. Participants will also interact with coaches throughout the intervention


Locations(1)

UCLA Mattel Children's Hospital

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04997473


Related Trials